These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23508528)

  • 1. Prediction of selective serotonin reuptake inhibitor response using diffusion-weighted MRI.
    Delorenzo C; Delaparte L; Thapa-Chhetry B; Miller JM; Mann JJ; Parsey RV
    Front Psychiatry; 2013; 4():5. PubMed ID: 23508528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining raphe-amygdala structural connectivity as a biological predictor of SSRI response.
    Pillai RLI; Huang C; LaBella A; Zhang M; Yang J; Trivedi M; Weissman M; McGrath P; Fava M; Kurian B; Cooper C; McInnis M; Oquendo MA; Pizzagalli DA; Parsey RV; DeLorenzo C
    J Affect Disord; 2019 Sep; 256():8-16. PubMed ID: 31158720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Pretreatment Amygdalae Serotonin Transporter Binding in Unipolar Depression Remitters: A Prospective PET Study.
    Ananth MR; DeLorenzo C; Yang J; Mann JJ; Parsey RV
    J Nucl Med; 2018 Apr; 59(4):665-670. PubMed ID: 28935838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
    Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
    JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas.
    Lanzenberger R; Kranz GS; Haeusler D; Akimova E; Savli M; Hahn A; Mitterhauser M; Spindelegger C; Philippe C; Fink M; Wadsak W; Karanikas G; Kasper S
    Neuroimage; 2012 Nov; 63(2):874-81. PubMed ID: 22828162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher serum DHEA concentrations before and after SSRI treatment are associated with remission of major depression.
    Hough CM; Lindqvist D; Epel ES; Denis MS; Reus VI; Bersani FS; Rosser R; Mahan L; Burke HM; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2017 Mar; 77():122-130. PubMed ID: 28038403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5-HTTLPR and BDNF polymorphisms moderate the association between uncinate fasciculus connectivity and antidepressants treatment response in major depression.
    Tatham EL; Hall GB; Clark D; Foster J; Ramasubbu R
    Eur Arch Psychiatry Clin Neurosci; 2017 Mar; 267(2):135-147. PubMed ID: 27277475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression.
    James GM; Baldinger-Melich P; Philippe C; Kranz GS; Vanicek T; Hahn A; Gryglewski G; Hienert M; Spies M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
    Front Hum Neurosci; 2017; 11():48. PubMed ID: 28220069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limbic system white matter microstructure and long-term treatment outcome in major depressive disorder: a diffusion tensor imaging study using legacy data.
    Hoogenboom WS; Perlis RH; Smoller JW; Zeng-Treitler Q; Gainer VS; Murphy SN; Churchill SE; Kohane IS; Shenton ME; Iosifescu DV
    World J Biol Psychiatry; 2014 Feb; 15(2):122-34. PubMed ID: 22540406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin 1A Receptor Binding of [11C]CUMI-101 in Bipolar Depression Quantified Using Positron Emission Tomography: Relationship to Psychopathology and Antidepressant Response.
    Lan MJ; Zanderigo F; Pantazatos SP; Sublette ME; Miller J; Ogden RT; Mann JJ
    Int J Neuropsychopharmacol; 2022 Aug; 25(7):534-544. PubMed ID: 34996114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
    Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A
    Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired myelin ultrastructure is reversed by citalopram treatment in a mouse model for major depressive disorder.
    Israel-Elgali I; Pan H; Oved K; Pillar N; Levy G; Barak B; Carneiro A; Gurwitz D; Shomron N
    J Psychiatr Res; 2023 Oct; 166():100-114. PubMed ID: 37757703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White Matter Indices of Medication Response in Major Depression: A Diffusion Tensor Imaging Study.
    Davis AD; Hassel S; Arnott SR; Harris J; Lam RW; Milev R; Rotzinger S; Zamyadi M; Frey BN; Minuzzi L; Strother SC; MacQueen GM; Kennedy SH; Hall GB
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Oct; 4(10):913-924. PubMed ID: 31471185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.
    Brendel M; Sauerbeck J; Greven S; Kotz S; Scheiwein F; Blautzik J; Delker A; Pogarell O; Ishii K; Bartenstein P; Rominger A;
    J Alzheimers Dis; 2018; 65(3):793-806. PubMed ID: 30010116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of early improvement of major depressive disorder to antidepressant medication in adolescents with radiomics analysis after ComBat harmonization based on multiscale structural MRI.
    Ma H; Zhang D; Wang Y; Ding Y; Yang J; Li K
    BMC Psychiatry; 2023 Jun; 23(1):466. PubMed ID: 37365541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.
    Vitiello B; Emslie G; Clarke G; Wagner KD; Asarnow JR; Keller MB; Birmaher B; Ryan ND; Kennard B; Mayes TL; DeBar L; Lynch F; Dickerson J; Strober M; Suddath R; McCracken JT; Spirito A; Onorato M; Zelazny J; Porta G; Iyengar S; Brent DA
    J Clin Psychiatry; 2011 Mar; 72(3):388-96. PubMed ID: 21208583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder.
    Korgaonkar MS; Rekshan W; Gordon E; Rush AJ; Williams LM; Blasey C; Grieve SM
    EBioMedicine; 2015 Jan; 2(1):37-45. PubMed ID: 26137532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant medication exposure and 5-HT
    Metts AV; Rubin-Falcone H; Ogden RT; Lin X; Wilner DE; Burke AK; Sublette ME; Oquendo MA; Miller JM; Mann JJ
    Synapse; 2019 Jun; 73(6):e22089. PubMed ID: 30693567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of selective serotonin and norepinephrine reuptake inhibitors on depressive- and impulsive-like behaviors and on monoamine transmission in experimental temporal lobe epilepsy.
    Kumar U; Medel-Matus JS; Redwine HM; Shin D; Hensler JG; Sankar R; Mazarati A
    Epilepsia; 2016 Mar; 57(3):506-15. PubMed ID: 26813337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.